Palliative chemoembolization of hepatocellular carcinoma with mitoxantrone, lipiodol, and gelfoam. A phase II study

Anticancer Research

Volumn 16, Issue 2, 1996, Pages 937-942

  Civalleri, Dario ^a   Pellicci, Riccardo ^a   Decaro, Giovanni ^b   Giangaspero, Antonio ^c   Ettorre, Giancarlo ^c   Decian, Franco ^a   Mondini, Guido ^a   Simoni, Gianantonio ^a  

^a UNIVERSITY OF GENOA   (Italy)

^b UNIVERSITY OF GENOA   (Italy)

^c UNIVERSITY OF BARI   (Italy)

Author keywords

Absorbablc; Chemoembolization; Iodized; Liver neoplasms; Mitoxantrone; Therapeutic; gelatin sponge

Indexed keywords

GELFOAM; IODINATED POPPYSEED OIL; MITOXANTRONE;

ADULT; AGED; ARTICLE; ARTIFICIAL EMBOLISM; ASCITES; BLEEDING; BONE MARROW SUPPRESSION; CANCER PALLIATIVE THERAPY; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL TRIAL; DIARRHEA; FEMALE; FEVER; HUMAN; JAUNDICE; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MALE; MULTICENTER STUDY; NAUSEA; PAIN; PANCREATITIS; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; VOMITING;

ANTINEOPLASTIC AGENTS; CARCINOMA, HEPATOCELLULAR; CHEMOEMBOLIZATION, THERAPEUTIC; FEMALE; GELATIN SPONGE, ABSORBABLE; HEMOSTATICS; HUMANS; IODIZED OIL; LIVER NEOPLASMS; MALE; MITOXANTRONE; PALLIATIVE CARE; PILOT PROJECTS;

EID: 0029977415     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Lotze MT, Flickinger JC, Carr BP. Cancer of the hepatobiliary system. In: Cancer, Principles & Practice of Oncology. DC Vita VT, Hellman S, Rosenberg SA, eds., JB. Lippincott, Philadelphia. 883-914, 1993.
2. Lee YTNM: Primary carcinoma of the liver: diagnosis, prognosis, and management. J Surg Oncol 22: 17-25, 1983.
3. Bhattacharya S, Novell JR, Winslet MC, Hobbs KR: Iodized oil in the treatment of hepatocellular carcinoma. Br J Surg 81: 1563-1571, 1994.
4. Taguchi T, Ogawa N, Bunke B, Nilsson B, and DSM-Study Group of Japan: The use of degradable starch microspheres (Spherex) with intraarterial chemotherapy for the treatment of primary and secondary liver tumours - results of a phase III clinical trial. Regional Cancer Treatment 4: 161-165, 1992.
5. Sugiura N, Takara K, Ohto M, Okuda K, Hirooka N: Percutaneous intratumoral injection of ethanol under ultrasound imaging for treatment of small hepatocellular carcinoma. Acta Hepatol Jpn 24: 920-925, 1983.
6. Anderson JH, Warren HW, McArdle CS. Clinical pharmacokinetic advantage of new drug delivery methods for the treatment of liver tumors. Clin Pharmacokinet 27: 191-201, 1994.
7. Civalleri D, Scopinaro G, Balletto N, Claudiani F, DeCian F, Camerini G, DePaoli M, Bonalumi U: Changes in vascularity of liver tumours after hepatic arterial embolization with degradable starch microspheres. Br J Surg 76: 699-703, 1989.
8. Willmott N: Chemoembolization in regional cancer chemotherapy: a rationale. Cancer Treat Rev 14: 143-156, 1987.
9. Collins JM: Pharmacologic rationale for regional drug delivery. J Clin Oncol 9: 498-504, 1984.
10. Civalleri D, Esposito, Fulco RA, Vannozzi M, Balletto N, DeCian F, Percivale PL, Merlo F: Liver and tumor uptake and plasma pharmacokinetic of arterial cisplatin administered with and without starch microspheres in patients with liver metastases. Cancer 68: 988-994, 1991.
11. Colleoni M, Noie F, DiBartolomeo M, de-Braud F, Bajetta E: Mitoxantrone in patients affected by hepatocellular carcinoma with unfavourable prognostic factors. Oncology 49: 139-142, 1992.
12. Sheperd FA, Evans WK, Blackstein ME, Fine S, Heathcote J, Langer B, Taylor B, Habal F, Kutas G, Pritchard KI, Kuruvilla P: Hepatic arterial infusion of mitoxantrone in the treatment of primary hepatocellular carcinoma. J Clin Oncol 5: 635-640, 1987.
13. Miller AB, Hoogstraten B, Staquet M, Winkler A: Reporting results of cancer treatment. Cancer 47: 207-214, 1981.
14. Pugh RNH, Murray-Lyon IM, Dawson JL, Pietroni ME, Williams R: Transection of the oesophagus for bleeding ocsophageal varices. Br J Surg 60: 646-649, 1973.
15. Beppu K, Inokuchi K, Koyanagi N, Nakayama S, Sakata H, Kitano S, Kobayashi M: Prediction of esophageal hemorrhage by esophageal endoscopy. Gastrointest Endosc 27: 213-218, 1981.
16. Sasaki Y, Imaoka S, Kasugai H, Fujita M, Kawamoto S, Ishiguro S, Kojima J, Ishikawa O, Ohigashi H, Furukawa H, Kojama H, Iwanaga T: A new approach to chemoembolization therapy for hepatoma using ethiozided oil, cisplatin, and gelatin sponge. Cancer 60: 1194-1203, 1987.
17. Fleming TR: One sample multiple testing procedure for phase II clinical trials. Biometrics. 38: 143-151, 1982.
18. Yamashita Y, Takahashi M, Koga Y, Suito R, Nanakawa S, Hatanaka Y, Sato N, Nakashima K, Urata J, Yoshizumi K, Ito K, Sumi S, Kan M: Prognostic factors in the treatment of hepatocellular carcinoma with transcatheter arterial embolization and arterial infusion. Cancer 67: 385-391, 1991.
19. Kawai S, Tani M, Okamura J, Ogawa M, Ohashi Y, Monden M, Hayashi S, Inoue S, Kawarada Y, Kusano M, Kubo Y, Kuroda C, Sakata Y, Shimamura Y, Jinno K, Takahashi A, Takayasu K, Tamura K, Nagasue N, Nakanishi Y, Makino M, Masuzawa M, Yumoto Y, Mori T, Oda T. and the Cooperative Study Group for Liver Cancer Treatment of Japan: Prospective and randomized clinical trial for the treatment of hepatocellular carcinoma. A comparison between L-TAE with farmorubicin and L-TAE with Adriamycin: Preliminary results (second cooperative study). Cancer Chemother Pharmacol 33 suppl: 97-102, 1994.
20. Watanabe S, Nishioka M, Ohta Y, Ogawa N, Ho S, Yamamoto Y Prospective and randomized controlled study of chemoembolization therapy in patients with advanced hepatocellular carcinoma. Cancer Chemother Pharmacol 33 suppl: 93-96, 1994.
21. Kawai S, Okamura J, Ogawa M, Ohashi Y, Tani M, Inoue J, Kawarada Y, Kusano M, Kubo Y, Kuroda C, Sakata Y, Shimamura Y, Jinno K, Takahashi A, Takayasu K, Tamura K, Nagasue N, Nakanishi Y, Makino M, Masuzawa M, Mikuriya S, Monden M, Yumoto Y, Mori T, Oda T, and the Cooperative Study Group for Liver Cancer Treatment of Japan: Prospective and randomized clinical trial for the treatment of hepatocellular carcinoma. A comparison of lipiodol-transcatheter arterial embolization with and without adriamycin (first cooperative study). Cancer Chemother Pharmacol 33 suppl: 1-6, 1994.
22. Groupe d'Etude et de Traitement du Carcinome Hepatocellulaire: A comparison of lipiodol chemoembolization and conservative treatment for unresectable hepatocellular carcinoma. N Engl J Med 332: 1256-1261, 1995.
23. Kasugai H, Kojima J, Tatsuta M, Okuda S, Sasaki Y, Imaoka S, Fujita M, Ishiguro S: Treatment of hepatocellular carcinoma by transcatheter arterial embolization combined with intraarterial infusion of a mixture of cisplatin and ethiozided oil. Gastroenterology 97: 965-971, 1984.
24. Chang JM, Tzeng WS, Pan HB, Yang CF, Lai KH: Transcatheter arterial embolization with or without cisplatin treatment of hepatocellular carcinoma. A randomized controlled study. Cancer 74: 2444-2453, 1994.
25. Lu CD, Qi YG, Peng SY: Lipiodolization with or without gelatin sponge in hepatic arterial chemoembolization for hepatocellular carcinoma. Chin Med J Engl 107: 209-215, 1994.
26. Pelletier G, Roche A, Ink O, Anciaux ML, Derhy S, Rougier P, Lenoir C, Attali P, Etienne JP. A randomized trial of hepatic arterial chemoembolization in patients with unresectable hepatocellular carcinoma. J Hepatol 11: 181-184, 1990.
27. Madden MV, Krige JEJ, Bailey D, Beningfield SJ, Geddes C, Werner ID, Terblanche J: Randomized trial of targeted chemotherapy with lipiodol and 5-epidoxorubicin compared with symptomatic treatment for hepatoma. Gut 34: 1598-1600, 1993.
28. Yoshikawa M, Saisho H, Ebara M, Iijima T, Iwama S, Endo F, Kimuro M, Shimamura Y, Suzuki Y, Nakano T, Fukuyama Y, Fujise K, Nambu M, Ohto M: A randomized trial od intrahepatic arterial infusion of 4′-epidoxorubicin with lipiodol versus 4′-epidoxorubicin alone in the treatment of hepatocellular carcinoma. Cancer Chemother Pharmacol 33 suppl: 149-152, 1994.
29. Marchiori L, Mansueto GC, Nifosi F, Bortolasi L, Dal-Dosso I, Facci E, Perus G, Nicoli N: II trattamento del carcinoma epatocellulare mediante chemioembolizzazione. Chir Ital 46: 17-22, 1994.
30. Ichikawa W, Togo S, Osanai T, Miyanaga T, Sawai S, Yamashita T, Kawachi Y, Nihei Z, Hirayama R, Mishima Y: Clinical study on the effect of intra-arterial injection of mitoxantrone-lipiodol emulsion for hepatocellular carcinoma. Gan To Kagaku Ryoho 21: 2212-2214, 1994.
31. Spreafico C, Marchiano A, Regalia E, Frigerio LE, Garbagnati F, Andreola S, Milella M, Lanocita R, Mazzaferro V, Chemoembolization of hepatocellular carcinoma in patients who undergo liver transplantation. Radiology 192: 687-690, 1994.
32. Tanaka K, Nakamura S, Numata K, Okazaki H, Endo O, Inoue S, Takamura Y, Sugiyama M, Ohaki Y: Hepatocellular carcinoma: treatment with percutaneous ethanol injection and transcatheter arterial embolization. Radiology 185: 457-460, 1992.